HIV & AIDS

US mulls lifting ban on gay blood donations (Update)

A US ban on blood donations by gays could be eased after 31 years, depending on the decision of a Food and Drug Administration advisory committee that began two days of meetings Tuesday.

Medications

Bristol-Myers: FDA blocks hepatitis C drug for now

U.S. regulators have declined to approve Bristol-Myers Squibb's daclatasvir as part of a combination hepatitis C treatment with another antiviral drug called asunaprevir.

Diseases, Conditions, Syndromes

FDA advisory panel says steroid shots for back pain can continue

(HealthDay)—An expert advisory panel to the U.S. Food and Drug Administration decided on Tuesday not to recommend the agency issue a strong warning against the general use of steroid injections for back pain.

Health

US orders calorie labeling for fast-food (Update)

The United States on Tuesday announced sweeping new rules forcing chain restaurants and pizza parlors to publish calorie counts on menus in an attempt to combat the nation's obesity epidemic.

Oncology & Cancer

FDA strengthens warning on device linked to cancer (Update)

U.S. regulators on Monday strengthened their warning against use of a once-popular device for gynecologic surgery that can spread unsuspected cancer, saying its risk is only justified in a fraction of patients.

Medications

US approves new, hard-to-abuse hydrocodone pill (Update)

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking such safeguards.

Medications

Two generic versions of ADHD drug not as effective: FDA

(HealthDay)—Two generic versions of the attention-deficit/hyperactivity disorder drug Concerta may not work as effectively as the brand-name product does, the U.S. Food and Drug Administration said Thursday.

Diseases, Conditions, Syndromes

Ebola drug testing sparks ethics debate

Health officials are scrambling to begin human testing of a handful of experimental drugs for Ebola. But the effort has sparked an ethical debate over how to study unproven medicines amid an outbreak that has killed nearly ...

page 15 from 40